SPARTON CORP (SPA) Fundamental Analysis & Valuation

NYSE:SPA • US8472351084

Current stock price

18.51
+0.02 (+0.11%)
At close:
18.51
0 (0%)
After Hours:

This SPA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

No Fundamental Analysis report for SPA not available.

SPA Fundamentals: All Metrics, Ratios and Statistics

SPARTON CORP

NYSE:SPA (3/4/2019, 8:32:01 PM)

After market: 18.51 0 (0%)

18.51

+0.02 (+0.11%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners74.88%
Inst Owner Change0%
Ins Owners3.46%
Ins Owner Change0%
Market Cap182.05M
Revenue(TTM)389.12M
Net Income(TTM)3.94M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)0%
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.81
Fwd PE N/A
P/S 0.47
P/FCF N/A
P/OCF N/A
P/B 2.41
P/tB N/A
EV/EBITDA 11.49
EPS(TTM)1.25
EY6.75%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS39.56
BVpS7.68
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 1.75%
ROE 5.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 3.52%
PM (TTM) 1.01%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.73
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.39
Altman-Z 2.73
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.05%
EPS 3YN/A
EPS 5Y-4.58%
EPS Q2Q%13.33%
EPS Next Y-100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.3%
Revenue growth 3YN/A
Revenue growth 5Y2.95%
Sales Q2Q%7.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

SPARTON CORP / SPA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SPARTON CORP (SPA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to SPA.


What is the valuation status of SPARTON CORP (SPA) stock?

ChartMill assigns a valuation rating of 3 / 10 to SPARTON CORP (SPA). This can be considered as Overvalued.


What is the profitability of SPA stock?

SPARTON CORP (SPA) has a profitability rating of 2 / 10.


What is the financial health of SPARTON CORP (SPA) stock?

The financial health rating of SPARTON CORP (SPA) is 3 / 10.


What is the expected EPS growth for SPARTON CORP (SPA) stock?

The Earnings per Share (EPS) of SPARTON CORP (SPA) is expected to decline by -100% in the next year.